Dementia is a major health issue worldwide in the 21st century, impacting over 50 million people globally. This figure is expected to soar to 152 million by 2050, as the global population ages. Alzheimer's disease (AD) is the leading type of dementia, responsible for 60–80% of all dementia cases.
Research on AD identifies two primary pathological hallmarks: the progressive accumulation of extracellular amyloid beta (Aβ) plaques and the presence of intracellular neurofibrillary tangles (NFTs).
The accumulation of these pathological proteins in specific brain regions, followed by their dissemination throughout the broader brain network, leads to disruptions in both individual brain regions and their interconnections. Consequently, brain networks play a pivotal role in the development and progression of AD.
Innovative Research in Alzheimer's Disease
In a study recently published in Psychoradiology, researchers from the University of Texas at Arlington and the University of Georgia have systematically summarized studies on brain networks within the context of AD, critically analyzed the strengths and weaknesses of existing methodologies, and offered novel perspectives and insights, intending to serve as inspiration for future research.
This study offers a comprehensive overview of the dynamic landscape of Alzheimer's disease (AD) research within the realm of brain network analysis. It underscores the pivotal role of brain networks in elucidating the mechanisms underpinning AD and their profound impact on disease progression.
Structural connectivity (SC) refers to anatomical links and is usually estimated using fiber bundles derived from diffusion MRI; Functional connectivity (FC) and effective connectivity (EC) are generally inferred through the correlation of nodal activities based on BOLD-fMRI or EEG/MEG. Credit: Psychoradiology
The review sheds light on the rich spectrum of graph-based methods employed in AD investigations, classifying them into traditional graph theory-based approaches and cutting-edge deep graph neural network-based techniques. These methodologies have significantly enriched our understanding of AD by unveiling intricate patterns within brain networks. Consequently, they have opened doors to pioneering diagnostic tools, predictive models, and the identification of potential biomarkers.
Moreover, this review highlights numerous substantial challenges lying ahead. These challenges encompass issues such as the interpretability of complex models and the effective integration of multimodal data, especially within the context of limited medical datasets. Addressing these hurdles remains paramount for the continued advancement of AD research and its translation into clinical practice.
Lead researcher, Dr. Lu Zhang, states, "Today, we have easier access to diverse modalities of data and possess more powerful computational models. I firmly believe that based on these advancements, we will ultimately overcome Alzheimer's disease in the near future."
Reference: "Exploring Alzheimer's disease: a comprehensive brain connectome-based survey" by Lu Zhang, Junqi Qu, Haotian Ma, Tong Chen, Tianming Liu and Dajiang Zhu, 11 January 2024, Psychoradiology.
DOI: 10.1093/psyrad/kkad033
News
Natural Compound in Broccoli Could Help Treat a Rare, Incurable Neurological Disease
Swinburne researchers have discovered how broccoli could help treat an extremely rare and incurable disease that affects only about 200 Australians. A naturally occurring compound in broccoli is being investigated as a possible treatment [...]
Antibody recycling, FcRn and the next generation of biologics
FcRn plays a central role in regulating the half-life of IgG antibodies and albumin, making it a critical target in both antibody engineering and autoimmune disease therapy. This article explores the biology of FcRn, [...]
Ebola kills 2,300 in three months with no vaccine available for Congo’s deadliest ever outbreak
It’s Congo’s 17th outbreak, with a toll that has eclipsed that of the country’s 2018-2020 outbreak when 2,299 deaths out of 3,481 cases were recorded. The latest data shows 101 new cases and 33 [...]
Beyond an Agency: How AI, Creativity and Commercialization Are Converging Into a New Growth Model
At a moment when AI is forcing a fundamental rethink of how work gets done, the life sciences industry is grappling with a deeper question: what role should human creativity play in an increasingly [...]
New $60 Blood Test Detects Lung Cancer Without Costly DNA Sequencing
A simple blood test that detects chemical changes in DNA identified more than 90% of stage 2-4 lung cancers in an early study, without relying on costly DNA sequencing. Researchers at Tel Aviv University and collaborating [...]
Reducing drug development failures with human-relevant models and AI
Professor Joseph C. Wu of Stanford University explains how stem cells, human-relevant models and AI are helping researchers predict which drug candidates are most likely to succeed before clinical trials. Researchers now have access [...]
Half of vaccines are binned – ‘fridge-free’ versions could change that
Vaccines that do not need to be kept cool in a fridge have been successfully trialed in patients for the first time, say UK scientists. Currently, most vaccines need to be refrigerated or frozen [...]
Mushroom Mystery: The Fungus That Makes People See Tiny Humans
A mushroom sold in markets and served in restaurants in Southwest China has an unusual warning attached to it: cook it thoroughly, or you may start seeing tiny people. For decades, people have reported [...]
Artificial intelligence used to design brand new viruses
Artificial Intelligence has been used to design brand new viruses that are fully functional and can replicate in the laboratory, say US researchers. It is the first time whole genomes have been successfully designed [...]
Molecular Manufacturing: The Future of Nanomedicine – New book from NanoappsMedical Inc.
This book explores the revolutionary potential of atomically precise manufacturing technologies to transform global healthcare, as well as practically every other sector across society. This forward-thinking volume examines how envisaged Factory@Home systems might enable the cost-effective [...]
Moderna kicks off Phase I Ebola trial as Africa readies itself for research
If the Phase I trial is successful, Moderna plans to quickly initiate Phase II and Phase III trials of its Ebola vaccine. Moderna has initiated a Phase I trial of its mRNA Ebola vaccine [...]
3D Human Brain Tissue Model Replicates Alzheimer’s Pathology
Summary: Researchers introduced a highly reproducible three-dimensional human brain tissue model capable of replicating complex neurodegenerative processes in Alzheimer’s disease. Developed over nine years using human stem cells, the self-organizing tissue spheroids integrate functional neurons, [...]
A Common Sugar May Loosen Cancer Cells and Help Them Spread
Chemotherapy may kill most ovarian cancer cells, but the few that survive can turn dangerously active. By releasing fructose, they may help nearby tumor cells break free and spread. Researchers at The Wistar Institute [...]
COVID-19 can wake up dormant viruses in the body, large study confirms
Virus reactivations by SARS-CoV-2 could worsen initial symptoms and increase risk of Long Covid. Early in the COVID-19 pandemic, scientists noticed that a SARS-CoV-2 infection can “wake up” other, dormant viruses already present in [...]
Scientists Discover the Brain May Enter a New Biological Phase Between 50 and 75
A single-cell study reveals major changes in immune cells, genome organization, and gene regulation within the aging human hippocampus, offering important insights into brain aging and dementias associated with age. Between roughly ages 50 [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
